血液腫瘍検査の世界市場2020-2027:、製品別(アッセイキット&試薬、サービス)、がん種類別、技術別、エンドユーザー別、地域別

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources & Third Party Perspectives
1.3.4 Primary Research
1.4 Information analysis
1.4.1 Data Analysis Models
1.5 Market formulation & data visualization
1.6 Data validation & publishing
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Hemato Oncology Testing Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 Penetration and Growth Prospect Mapping
3.2.1 User perspective analysis
3.2.1.1 Consumer behavior analysis
3.3 Regulatory Framework
3.3.1 Reimbursement framework
3.3.2 Standards and compliances
3.4 Market Dynamics
3.4.1 Market driver analysis
3.4.1.1 Increasing prevalence of lymphoma & myeloma
3.4.1.2 Growing demand for personalized therapy
3.4.1.3 Availability of advanced molecular techniques for hemato-oncology diagnostics
3.4.1.4 Increasing drug-diagnostics co-development
3.4.2 Market restraint analysis
3.4.2.1 Unfavorable reimbursement scenario
3.4.3 Market opportunities analysis
3.4.3.1 Developing countries provide untapped markets for multinational players
3.4.4 Market challenges analysis
3.4.4.1 Intellectual property rights protection issues
3.5 Hemato Oncology Testing Market Analysis Tools
3.5.1 INDUSTRY ANALYSIS – PORTER’S
3.5.1.1 Supplier Power
3.5.1.2 Buyer Power
3.5.1.3 Substitution Threat
3.5.1.4 Threat from new entrants
3.5.1.5 Competitive Rivalry
3.5.2 PESTEL ANALYSIS
3.5.2.1 Political Landscape
3.5.2.2 Environmental Landscape
3.5.2.3 Social landscape
3.5.2.4 Services landscape
3.5.2.5 Legal Landscape
3.5.3 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
3.5.3.1 Joint ventures
3.5.3.2 Mergers and acquisitions
3.5.3.3 Licensing and partnership
3.5.3.4 Services collaborations
3.5.3.5 Strategic Divestments
Chapter 4 Hemato Oncology Testing Market – Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company Categorization
4.2.1 List of key distributors and channel partners
4.2.2 Key company market share analysis, 2019
4.3 Public Companies
4.3.1 Company market position analysis
4.4 Private Companies
4.4.1 List of key emerging companies
4.4.2 Regional network map
4.4.3 Company market position analysis
Chapter 5 Hemato Oncology Testing Market: Cancer Type Estimates and Trend Analysis
5.1 Definition & Scope
5.2 Cancer Type Market Share Analysis, 2019 & 2027
5.3 Segment Dashboard
5.4 Global Hemato Oncology Testing Market, by Cancer Type, 2016 to 2027
5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
5.6 Leukemia
5.6.1 Leukemia Market, 2016 To 2027 (USD Million)
5.6.1.1 Acute Myeloid Leukemia
5.6.1.1.1 Acute Myeloid Leukemia Market, 2016 To 2027 (USD Million)
5.6.1.2 Acute Lymphocytic Leukemia
5.6.1.2.1 Acute Lymphocytic Leukemia Market, 2016 To 2027 (USD Million)
5.6.1.3 Chronic Lymphocytic Leukemia
5.6.1.3.1 Chronic Lymphocytic Leukemia Market, 2016 To 2027 (USD Million)
5.6.1.4 Chronic Myeloid Leukemia
5.6.1.4.1 Chronic Myeloid Leukemia Market, 2016 To 2027 (USD Million)
5.7 Lymphoma
5.7.1 Lymphoma Market, 2016 To 2027 (USD Million)
5.7.1.1 Non-Hodgkin Lymphoma
5.7.1.1.1 Non-Hodgkin Lymphoma Market, 2016 To 2027 (USD Million)
5.7.1.2 Hodgkin Lymphoma
5.7.1.2.1 Hodgkin Lymphoma Market, 2016 To 2027 (USD Million)
5.8 Myeloproliferative Neoplasms
5.8.1 Myeloproliferative Neoplasms Market, 2016 TO 2027 (USD Million)
5.8.1.1 Polycythemia vera
5.8.1.1.1 Polycythemia vera Market, 2016 to 2027 (USD Million)
5.8.1.2 Essential thrombocythemia
5.8.1.2.1 Essential thrombocythemia Market, 2016 to 2027 (USD Million)
5.8.1.3 Myelofibrosis
5.8.1.3.1 Myelofibrosis Market, 2016 to 2027 (USD Million)
5.9 Other Cancers
5.9.1 OTHER CANCERS MARKET, 2016 TO 2027 (USD Million)
Chapter 6 Hemato Oncology Testing Market: Product Estimates and Trend Analysis
6.1 Definition & Scope
6.2 Product Market Share Analysis, 2019 & 2027
6.3 Segment Dashboard
6.4 Global Hemato Oncology Testing Market, by Product, 2016 to 2027
6.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
6.6 Assay Kits and Reagents
6.6.1 Assay Kits And Reagents Market, 2016 To 2027 (USD Million)
6.7 Services
6.7.1 Services Market, 2016 To 2027 (USD Million)
Chapter 7 Hemato Oncology Testing Market: Technology Estimates and Trend Analysis
7.1 Definition & Scope
7.2 Technology Market Share Analysis, 2019 & 2027
7.3 Segment Dashboard
7.4 Global Hemato Oncology Testing Market, by Technology, 2016 to 2027
7.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
7.6 PCR
7.6.1 PCR MARKET, 2016 TO 2027 (USD Million)
7.6.1.1 Real-time qPCR
7.6.1.1.1 Real-time qPCR Market, 2016 to 2027 (USD Million)
7.6.1.2 Digital PCR
7.6.1.2.1 Digital PCR Market, 2016 to 2027 (USD Million)
7.7 IHC
7.7.1 IHC MARKET, 2016 TO 2027 (USD Million)
7.8 NGS
7.8.1 NGS MARKET, 2016 TO 2027 (USD Million)
7.9 Cytogenetics
7.9.1 CYTOGENETICS MARKET, 2016 TO 2027 (USD Million)
7.10 Other Technologies
7.10.1 OTHER TECHNOLOGIES MARKET, 2016 TO 2027 (USD Million)
Chapter 8 Hemato Oncology Testing Market: End Use Estimates and Trend Analysis
8.1 Definition & Scope
8.2 End Use Market Share Analysis, 2019 & 2027
8.3 Segment Dashboard
8.4 Global Hemato Oncology Testing Market, by End Use, 2016 to 2027
8.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
8.6 Hospitals
8.6.1 Hospitals Market, 2016 TO 2027 (USD Million)
8.7 Academic & Research Institutes
8.7.1 Academic & Research Institutes Market, 2016 TO 2027 (USD Million)
8.8 Others
8.8.1 Others Market, 2016 TO 2027 (USD Million)
Chapter 9 Hemato Oncology Testing Market: Regional Estimates & Trend Analysis
9.1 Regional Market Snapshot
9.2 Market Share Analysis by Country, 2019
9.2.1 NORTH AMERICA
9.2.1.1 U.S.
9.2.1.2 Canada
9.2.2 EUROPE
9.2.2.1 U.K.
9.2.2.2 Germany
9.2.2.3 Spain
9.2.2.4 France
9.2.2.5 Italy
9.2.2.6 Russia
9.2.3 LATIN AMERICA
9.2.3.1 Brazil
9.2.3.2 Mexico
9.2.3.3 Argentina
9.2.4 ASIA PACIFIC
9.2.4.1 Japan
9.2.4.2 China
9.2.4.3 India
9.2.4.4 South Korea
9.2.4.5 Australia
9.2.4.6 Singapore
9.2.5 MIDDLE EAST & AFRICA
9.2.5.1 South Africa
9.2.5.2 Saudi Arabia
9.2.5.3 UAE
9.3 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
9.3.1 NORTH AMERICA
9.3.2 EUROPE
9.3.3 LATIN AMERICA
9.3.4 ASIA PACIFIC
9.3.5 MIDDLE EAST & AFRICA
9.4 Market Size & Forecasts, and Trend Analysis, 2016 to 2027
9.4.1 NORTH AMERICA
9.4.1.1 North America Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.4.1.2 U.S.
9.4.1.2.1 U.S. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.1.2.2 U.S. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.1.2.3 U.S. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.1.2.4 U.S. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.1.3 Canada
9.4.1.3.1 Canada Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.1.3.2 Canada Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.1.3.3 Canada Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.1.3.4 Canada Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.2 EUROPE
9.4.2.1 Europe Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.4.2.2 U.K.
9.4.2.2.1 U.K. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.2.2.2 U.K. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.2.2.3 U.K. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.2.2.4 U.K. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.2.3 Germany
9.4.2.3.1 Germany Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.2.3.2 Germany Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.2.3.3 Germany Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.2.3.4 Germany Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.2.4 France
9.4.2.4.1 France Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.2.4.2 France Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.2.4.3 France Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.2.4.4 France Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.2.5 Italy
9.4.2.5.1 Italy Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.2.5.2 Italy Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.2.5.3 Italy Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.2.5.4 Italy Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.2.6 Spain
9.4.2.6.1 Spain Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.2.6.2 Spain Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.2.6.3 Spain Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.2.6.4 Spain Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.2.7 Russia
9.4.2.7.1 Russia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.2.7.2 Russia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.2.7.3 Russia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.2.7.4 Russia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.3 ASIA PACIFIC
9.4.3.1 Asia Pacific Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.4.3.2 Japan
9.4.3.2.1 Japan Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.3.2.2 Japan Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.3.2.3 Japan Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.3.2.4 Japan Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.3.3 China
9.4.3.3.1 China Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.3.3.2 China Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.3.3.3 China Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.3.3.4 China Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.3.4 India
9.4.3.4.1 India Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.3.4.2 India Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.3.4.3 India Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.3.4.4 India Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.3.5 South Korea
9.4.3.5.1 South Korea Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.3.5.2 South Korea Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.3.5.3 South Korea Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.3.5.4 South Korea Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.3.6 Australia
9.4.3.6.1 Australia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.3.6.2 Australia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.3.6.3 Australia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.3.6.4 Australia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.3.7 Singapore
9.4.3.7.1 Singapore Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.3.7.2 Singapore Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.3.7.3 Singapore Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.3.7.4 Singapore Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.4 LATIN AMERICA
9.4.4.1 Latin America Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.4.4.2 Brazil
9.4.4.2.1 Brazil Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.4.2.2 Brazil Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.4.2.3 Brazil Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.4.2.4 Brazil Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.4.3 Mexico
9.4.4.3.1 Mexico Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.4.3.2 Mexico Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.4.3.3 Mexico Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.4.3.4 Mexico Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.4.4 Argentina
9.4.4.4.1 Argentina Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.4.4.2 Argentina Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.4.4.3 Argentina Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.4.4.4 Argentina Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.5 MIDDLE EAST & AFRICA
9.4.5.1 Middle East & Africa Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.4.5.2 South Africa
9.4.5.2.1 South Africa Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.5.2.2 South Africa Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.5.2.3 South Africa Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.5.2.4 South Africa Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.5.3 Saudi Arabia
9.4.5.3.1 Saudi Arabia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.5.3.2 Saudi Arabia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.5.3.3 Saudi Arabia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.5.3.4 Saudi Arabia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.5.4 UAE
9.4.5.4.1 UAE Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.5.4.2 UAE Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.5.4.3 UAE Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.5.4.4 UAE Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
Chapter 10 COMPANY PROFILES
10.1 Company Profiles
10.1.1 F. HOFFMAN-LA ROCHE LTD.
10.1.1.1 Company overview
10.1.1.2 Financial performance
10.1.1.3 Product benchmarking
10.1.1.4 Strategic initiatives
10.1.2 ABBOTT LABORATORIES
10.1.2.1 Company overview
10.1.2.2 Financial performance
10.1.2.3 Product benchmarking
10.1.2.4 Strategic initiatives
10.1.3 QIAGEN N.V.
10.1.3.1 Company overview
10.1.3.2 Financial performance
10.1.3.3 Product benchmarking
10.1.3.4 Strategic initiatives
10.1.4 THERMO FISHER SCIENTIFIC, INC.
10.1.4.1 Company overview
10.1.4.2 Financial performance
10.1.4.3 Product benchmarking
10.1.4.4 Strategic initiatives
10.1.5 ILLUMINA, INC.
10.1.5.1 Company overview
10.1.5.2 Financial performance
10.1.5.3 Product benchmarking
10.1.5.4 Strategic initiatives
10.1.6 BIO-RAD LABORATORIES, INC.
10.1.6.1 Company overview
10.1.6.2 Financial performance
10.1.6.3 Product benchmarking
10.1.6.4 Strategic initiatives
10.1.7 MOLECULARMD
10.1.7.1 Company overview
10.1.7.2 Financial performance
10.1.7.3 Product benchmarking
10.1.7.4 Strategic initiatives
10.1.8 ARCHERDX, INC.
10.1.8.1 Company overview
10.1.8.2 Financial performance
10.1.8.3 Product benchmarking
10.1.8.4 Strategic initiatives
10.1.9 ARUP LABORATORIES INC.
10.1.9.1 Company overview
10.1.9.2 Financial performance
10.1.9.3 Product benchmarking
10.1.9.4 Strategic initiatives
10.1.10 ASURAGEN, INC.
10.1.10.1 Company overview
10.1.10.2 Financial performance
10.1.10.3 Product benchmarking
10.1.10.4 Strategic initiatives
10.1.11 INVIVOSCRIBE, INC.
10.1.11.1 Company overview
10.1.11.2 Financial performance
10.1.11.3 Product benchmarking
10.1.11.4 Strategic initiatives
10.1.12 ADAPTIVE BIOTECHNOLOGIES
10.1.12.1 Company overview
10.1.12.2 Financial performance
10.1.12.3 Product benchmarking
10.1.12.4 Strategic initiatives
10.1.13 CEPHEID
10.1.13.1 Company overview
10.1.13.2 Financial performance
10.1.13.3 Product benchmarking
10.1.13.4 Strategic initiatives
10.1.14 ENTROGEN, INC.
10.1.14.1 Company overview
10.1.14.2 Financial performance
10.1.14.3 Product benchmarking
10.1.14.4 Strategic initiatives
10.1.15 AMOY DIAGNOSTICS CO., LTD
10.1.15.1 Company overview
10.1.15.2 Financial performance
10.1.15.3 Product benchmarking
10.1.15.4 Strategic initiatives

グローバル市場調査会社